Patient
SITE007-0236
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2026-06-12
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-23
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 62); relationship: not assessed
mild
assessed
2026-07-06
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-30 (study day 14); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.